🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,557 results for “placebo” Clear

  1. Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 °C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE

    Disc Medicine

    Autosomal Dominant Polycystic Kidney Disease

    approved small molecule active

    1 trial

  2. Placebo, Desloratadine 5 mg orodispersible tablets, Bactil Flas 10 mg Liofilizados orales, Bilaxten 20 mg comprimidos bucodispersables

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergy

    approved small molecule active

    1 trial

  3. Placebo: PL1, Pharmaceutical form: Capsule, Route of administration: Oral use, Hydrocortison DMB 20 mg, tabletten

    Disc Medicine

    Posttraumatic Stress Disorder (PTSD)

    approved small molecule active

    1 trial

  4. Quetiapine and placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Disorder

    approved small molecule completed

    1 trial

  5. RINVOQ 45 mg prolonged-release tablets, Placebo to Match Blinded Upadacitinib, Entyvio 300 mg powder for concentrate for solution for infusion

    Takeda

    Chron's Disease

    approved small molecule active

    1 trial

  6. RIVASTIGMINE, Rivastigmin adhesive plaster 9.5 mg placebo containing 0 mg of rivastigmin, Rivastigmin adhesive plaster 4.6 mg placebo containing 0 mg of rivastigmin, RIVASTIGMINE

    Disc Medicine

    Depression

    approved small molecule active

    1 trial

  7. ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, Placebo to KJX839 (Inclisiran sodium) 0 mg/1.5 mL solution for injection in pre-filled syringe, INCLISIRAN

    Novartis Pharmaceuticals

    Hypercholesterolemia

    approved small molecule active

    1 trial

  8. Ramelteon and Placebo

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved small molecule completed

    2 trials

  9. Ramelteon, zolpidem and placebo

    Takeda

    Insomnia

    approved small molecule completed

    1 trial

  10. Rasagiline/Placebo

    Teva Pharma GmbH

    Parkinson's Disease

    approved small molecule completed

    1 trial

  11. TRALOKINUMAB, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.

    LEO Pharma A/S

    Atopic dermatitis and moderate-to severe atopic hand eczema

    approved small molecule active

    1 trial

  12. The Placebo used for the clinical trial is a sterile saline solution (0.9% w/v solution of NaCl in water) supplied in 1.25 mL pre-filled glass syringes., Shingrix suspension for injection in pre filled syringe Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Incident dementia

    approved small molecule active

    1 trial

  13. The placebo MDI is formulated as a suspension of spray-dried porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC] and calcium chloride) in a hydrofluoroalkane propellant (HFA-134a). The placebo MDI uses the same excipients as active product but with absence of the active pharmaceutical ingredient (API)., Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension

    AstraZeneca AB

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial

  14. The placebo has the same composition as the investigational medicinal product alkacitrat effervescent tablet 2 g/tab (with the exception of the active substance), is manufactured by the same manufacturer (uni-pharma kleon tsetis pharmaceutical laboratory s.a) and is not sterile., ALKACITRAT Αναβράζον δισκίο 2 g/tab

    Lacuna Pharma Pty Ltd

    Functional Dyspepsia

    approved small molecule active

    1 trial

  15. VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg

    Pfizer Australia Pty Ltd

    Migraine attacks with or without aura

    approved small molecule active

    1 trial

  16. Vedolizumab Placebo

    Takeda

    Pouchitis

    approved small molecule completed

    1 trial

  17. cagrilintide, Placebo + Placebo, semaglutide, cagrilintide, cagrilintide semaglutide, semaglutide, semaglutide, semaglutide, cagrilintide semaglutide, semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide, cagrilintide

    NovoThirteen

    Obesity and T2D

    approved small molecule active

    1 trial

  18. placebo

    Shandong University

    Sedation

    approved small molecule active

    1 trial

  19. placebo

    Takeda

    Constipation

    approved small molecule completed

    1 trial

  20. Alcohol(oral) and placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Drinking

    small molecule completed

    1 trial

  21. DAOSiN®/ Placebo & ProvokAmin® Ingestion

    Century Therapeutics

    Histamine Intolerance

    other completed

    1 trial

  22. Inhaled Placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ventilator-Associated Pneumonia (VAP)

    small molecule active

    1 trial

  23. Normal Saline (Placebo)

    The First People's Hospital of Lianyungang

    Disease of Respiratory System

    small molecule completed

    1 trial

  24. Open Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Pain

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources